How to prevent mutton sheep from falling out

Increase nutrition: First, feed high-quality forage; Second, supplement concentrates; Third, supplement salt; Fourth, increase drinking water.

Shelter management should be done to prevent the heat and cool down. Open the air convection window at the bottom of the south and the south wall of the sheep house, and set up the sun awning on the sun surface; if the sheep house is a flat tile roof, you can brush white lime or cover the shade. In addition, screens should be installed to prevent fly mosquitoes from entering.

Early and late grazing is carried out by grazing early and late. Before 9 o'clock in the morning, the mutton sheep must return to laps and go out to grazing after 5 o'clock in the afternoon.

Supplementary feeding at night should be dry and grass feed.

Prevention and control of pests must be periodically repelled; second, prevention and treatment of diarrhea. When sheep diarrhea, you can use the morning fasting orally 2 80,000 units gentamicin, and even served 2 days; Third, to strengthen the immunization. For sheep that have not been injected with the W vaccine or the goatpox vaccine, it is necessary to refill the vaccine.

Enzalutamide Intermediates

The chemical formula of enzalutamide is 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thione -1-imidazolidinyl]-2-fluoro-N-methylbenzamide, its clinical drug was jointly developed by Medivation and Astellas, and approved by the US Food and Drug Administration on August 31, 2012 FDA-approved for the treatment of advanced male castration-resistant prostate cancer that has spread or recurred under the trade name Xtandi[1], which is available as an oral preparation. Enzalutamide (MDV 3100) is an androgen receptor antagonist that blocks androgen binding to the androgen receptor and prevents nuclear translocation and coactivator recruitment of the ligand-receptor complex. MDV 3100 has also been shown to induce tumor cell apoptosis and has no agonist activity. MDV 3100 is a candidate for the treatment of castration-resistant prostate cancer.

Cas 143782-23-4,Enzalutamide Intermediates,6-Bromo-2-Chloro-8-Cyclopentyl

Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd , https://www.dingminpharma.com